Vivo Ventures, the California-China healthcare venture capital company, is the lead investor in a $30 million funding round for Shanghai Jingfeng Pharmaceutical Co., according to Venture Wire.
http://seekingalpha.com/article/998221-china-biotech-in-review-singapore-company-completes-investment-in-novabay?source=feed
http://seekingalpha.com/article/998221-china-biotech-in-review-singapore-company-completes-investment-in-novabay?source=feed
No comments:
Post a Comment